Kathleen P. Gallagher Insider Profile
4 Followers
Kathleen P. Gallagher, CEO and President, Director at Atrium Therapeutics, Inc., holds 119.73K shares in Atrium Therapeutics, Inc. (Ticker: RNA), holds 0.00 shares in Avidity Biosciences (Ticker: RNAM).
Kathleen P. Gallagher's Trading History
| RNAAtrium Therapeutics, Inc. | Sep 22, 2026 | CEO and President, Director | Uninformative Sell | 104.11K | $953.04K | |
| RNAMAvidity Biosciences | Feb 27, 2026 | ― | Uninformative Sell | ― | $0.00 |
You May Also Like
Kathleen P. Gallagher insider profile FAQ
What stocks does Kathleen P. Gallagher hold?
Kathleen P. Gallagher holds: RNA, RNAM stocks.
What was Kathleen P. Gallagher’s latest transaction?
Kathleen P. Gallagher’s latest transaction was an Uninformative Sell of $104.11K.
What is Kathleen P. Gallagher's role in Atrium Therapeutics, Inc.?
Kathleen P. Gallagher's role in Atrium Therapeutics, Inc. is CEO and President, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
